Please provide your email address to receive an email when new articles are posted on . HBV birth dose vaccination with antiviral prophylaxis in pregnant women with high viral load could avert 1.1 ...

The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in chronic ...

Chief, Digestive Disease Institute, North Shore University Hospital-Long Island Jewish Medical Center, Manhasset, New York; Associate Professor of Medicine, New York University School of Medicine, New ...

A recent study published in Alimentary Pharmacology and Therapeutics reports that patients with a lower hepatitis B virus (HBV) haplotype number of less than or equal to two are more likely to achieve ...

Please provide your email address to receive an email when new articles are posted on . AGA guidance strongly recommends antiviral prophylaxis for patients at high risk for hepatitis B reactivation.

Among patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF), treatment with potent, first-line antivirals entecavir (ETV), tenofovir disoproxil fumarate (TDF), or ...

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer than six months are considered "chronic." Chronic hepatitis B (CHB) poses ...

Globally, the hepatitis B virus is a major cause of mortality from infectious diseases. Around 250 million people suffer from chronic HBV infections, with the virus being responsible for over one ...

Precision BioSciences Presents Late-Breaking Phase 1 PBGENE-HBV Data at AASLD The Liver Meeting® Showing Safety, Tolerability and Cumulative, Dose-Dependent Antiviral Activity in First Three Cohorts ...

Viral hepatitis is an infection of the liver with one of five strains of the hepatitis virus (A, B, C, D, or E), resulting in liver inflammation and damage. Hepatitis ...